UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report:
(Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
(Address of principal executive offices) | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
N/A | N/A | N/A |
Securities registered pursuant to Section 12(g) of the Act:
Title of each Class | Trading Symbol | Name of Each Exchange on Which Registered |
OTC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 | Other Material Event |
On May 23, 2025, Financial Industry Regulatory Authority (“FINRA”) approved Odyssey Group International, Inc.’s name change on the OTC Markets to Odyssey Health, Inc., effective as of May 27, 2025. The name change was approved by the shareholders at the September 14, 2021, annual shareholder meeting and was effectuated by the State of Nevada via an amendment to the issuer’s Articles of Incorporation filed December 1, 2021, and effective October 8, 2021.
The current OTC Market symbol ODYY remains the same.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Odyssey Health, Inc. | ||
Date: May 29, 2025 | By: | /s/ Joseph Michael Redmond |
Joseph Michael Redmond Chief Executive Officer |
3 |